Thiamylal

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Thiamylal
ThiamylalSVG.svg
Clinical data
AHFS/Drugs.com International Drug Names
ATCvet code
Legal status
Legal status
Pharmacokinetic data
Metabolism Hepatic
Biological half-life 14.3 h (cats)
Identifiers
Synonyms Thiamylal, Thioseconal, Surital
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
ECHA InfoCard 100.000.927
Chemical and physical data
Formula C12H18N2O2S
Molar mass 254.35 g/mol
3D model (Jmol)
  (verify)

Thiamylal (Surital) is a barbiturate derivative invented in the 1950s. It has sedative, anticonvulsant, and hypnotic effects, and is used as a strong but short acting sedative. Thiamylal is still in current use, primarily for induction in surgical anaesthesia [1] or as an anticonvulsant to counteract side effects from other anaesthetics.[2] It is the thiobarbiturate analogue of secobarbital.

References[edit]

  1. ^ Hsieh MY, Hung GY, Hsieh YL, Chang CY, Hwang B. Deep sedation with methohexital or thiamylal with midazolam for invasive procedures in children with acute lymphoblastic leukemia. Acta Paediatrica Taiwan. 2005 Sep-Oct;46(5):294-300.
  2. ^ Tsai CJ, Wang HM, Lu IC, Tai CF, Wang LF, Soo LY, Lu DV. Seizure after local anesthesia for nasopharyngeal angiofibroma. Kaohsiung Journal of Medical Sciences. 2007 Feb;23(2):97-100.